Israeli bio-techs merge

I reported previously (see here) on Jerusalem-based immunotherapy company Enlivex Therapeutics. Enlivex has merged with Tel Aviv-headquartered Bioblast (see here), which is developing treatments for rare genetic diseases.,7340,L-3759270,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.